Ignite Creation Date:
2024-05-05 @ 9:27 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00005096
Status:
COMPLETED
Last Update Posted:
2017-07-14
First Post:
2000-04-06
Brief Title:
Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute